BackBolt Biotherapeutics Overview

Bolt Biotherapeutics Total Assets

Bolt Biotherapeutics's total assets is $40M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$40.34M
↓ 46.56% YoYΔ $-35.16M vs prior year quarter

Peer trimmed avg / median

Loading

Bolt Biotherapeutics Total Assets History

Loading

Bolt Biotherapeutics vs. peers: Total Assets Comparison

Loading

Bolt Biotherapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bolt Biotherapeutics (BOLT) FAQ

As of the most recent data (June 2026), BOLT shows a total assets of $40M. That compares with $75M in the prior-year period — down 46.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BOLT's total assets is now $40M (was $75M) — a 46.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bolt Biotherapeutics is outperforming or lagging.

Tracking BOLT's total assets over time shows whether Bolt Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $40M That compares with $75M in the prior-year period — down 46.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Bolt Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $40M) with ownership activity and broader fundamentals.

Bolt Biotherapeutics's total assets is $40M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.